926297-35-0

Basic information

• Product Name: ethyl (2E)-3-{2-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}-4-[2-ethoxy-1-(ethoxymethyl)ethoxy]phenyl}acrylate
• Synonyms: ethyl (2E)-3-{2-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}-4-[2-ethoxy-1-(ethoxymethyl)ethoxy]phenyl}acrylate
• CAS NO: 926297-35-0
• Molecular Weight: 517.93
• Mol File: 926297-35-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: ethyl (2E)-3-{2-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}-4-[2-ethoxy-1-(ethoxymethyl)ethoxy]phenyl}acrylate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl (2E)-3-{2-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}-4-[2-ethoxy-1-(ethoxymethyl)ethoxy]phenyl}acrylate(926297-35-0)
• EPA Substance Registry System: ethyl (2E)-3-{2-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}-4-[2-ethoxy-1-(ethoxymethyl)ethoxy]phenyl}acrylate(926297-35-0)

Safety Data

• Hazardous Substances Data: 926297-35-0(Hazardous Substances Data)

Upstream product

• 926295-27-4 ethyl (2E)-3-(2-([3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy)-4-hydroxyphenyl)acrylate 
• 4043-59-8 1,3-diethoxy-isopropanol 

Relevant articles and documents

THERAPEUTIC AGENT FOR DIABETES

The present invention provides an agent for the prophylaxis or treatment of diabetes, which is associated with a ferwer side effects such as body weight gain, adipocyte accumulation, cardiac hypertrophy and the like, and which contains a compound represented by the formula: wherein each symbol is as defined in the specification, or a salt thereof or a prodrug thereof.